Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes.

Diabetes care - 1 Jan 2017

Fadini Gian Paolo, Rigato Mauro, Cappellari Roberta, Bonora Benedetta Maria, Avogaro Angelo

Abstract excerpt

OBJECTIVE: Cardiovascular risk varies substantially in the population with diabetes, and biomarkers can improve risk stratification. Circulating stem cells predict future cardiovascular events and death, but data for the population with diabetes are scant. In this study we evaluated the ability of circulating stem cell levels to predict future cardiovascular outcomes and improve risk discrimination in patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Antigens, CD34

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Cell Count

Share to Predictive Value of Tests

Share to Proportional Hazards Models

Share to Regression Analysis

Share to Stem Cells

Source

Identifiers

PMID: 27815289
DOI: 10.2337/dc16-1755

Genes

KDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes.PMID 27815289Read ↗

Precision Prognostics for Cardiovascular Disease in Type 2 Diabetes: A Systematic Review and Meta-analysisSemantic proximity Read ↗

Precision Prognostics for Cardiovascular Disease in Type 2 Diabetes: A Systematic Review and Meta-analysisSemantic proximity Read ↗

Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes.Semantic proximity Read ↗

Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes.Semantic proximity Read ↗

Disease overarching mechanisms that explain and predict outcome of patients with high cardiovascular risk: rationale and design of the Berlin Long-term Observation of Vascular Events (BeLOVE) studySemantic proximity Read ↗

Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study.Semantic proximity Read ↗

Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: Results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortiumSemantic proximity Read ↗

Disease overarching mechanisms that explain and predict outcome of patients with high cardiovascular risk: rationale and design of the Berlin Long-term Observation of Vascular Events (BeLOVE) studySemantic proximity Read ↗

Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study.Semantic proximity Read ↗

Stromal cell-derived factor 1 as a biomarker of heart failure and mortality risk.Semantic proximity Read ↗

Circulating CD34+ progenitor cell frequency is associated with clinical and genetic factorsSemantic proximity Read ↗

Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.